YANTAI, China, June 5, 2024 /PRNewswire/ — RemeGen Co., Ltd. (“RemeGen” or “the Company”) (9995.HK, SHA: 688331), a commercial-stage biotechnology company, showcased its innovation in the field of global cancer treatment at the American Society of Clinical Oncology Annual Meeting (ASCO…

SEATTLE, June 5, 2024 /PRNewswire/ — JND Legal Notification — A proposed settlement has been reached in a class action lawsuit called Jane Doe, et al. v MasterCorp., Inc., Case No. 1:24-cv-00678 (E.D. Va.) (the “Settlement”). The Settlement is between Jane Doe, John Doe 1, and John Doe…

SEATTLE, 5 de junio de 2024 /PRNewswire-HISPANIC PR WIRE/ — Notificación legal de JND — Se ha llegado a un acuerdo propuesto en una demanda colectiva llamada Jane Doe, et al. contra MasterCorp., Inc., Caso No. 1:24-cv-00678 (e.d. Va.) (el “Acuerdo”). El Acuerdo es entre Jane Doe, John…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.